In the present study, we focused on the recurrence of IDH mutant gliomas, particularly those harboring TP53 mutations and found three major results: First, we clarified that only tumors with TP53 mutations showed remote intracranial recurrence and that the recurrence might occur via major fiber bundles. This evidence concerns the gene IDH1 and central nervous system cancer.